SCHEMBL14880933

SCHEMBL14880933

CCOC(=O)[C@@H]1C[C@H]1c1ccccc1OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.51
HTR2B P41595 1/20 0.51
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
PTGER1 P34995 2/20 0.48
DRD2 P14416 1/20 0.48
DRD1 P21728 1/20 0.48
TBXA2R P21731 1/20 0.48
DRD4 P21917 1/20 0.48
DRD5 P21918 1/20 0.48
PTGER4 P35408 1/20 0.48
DRD3 P35462 1/20 0.48
PTGFR P43088 1/20 0.48
PTGER3 P43115 1/20 0.48
PTGER2 P43116 1/20 0.48
PTGIR P43119 1/20 0.48
MAPT P10636 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22181196 1.00 HTR2C (0.51) HTR2CHTR2BMEN1KMT2APTGER1
SCHEMBL31562844 0.88 PTGER1 (0.43) HTR2CHTR2BMEN1KMT2APTGER1
SCHEMBL31562515 0.86 PTGER1 (0.42) HTR2CHTR2BMEN1KMT2APTGER1
SCHEMBL22181584 0.84 PTGER1 (0.63) HTR2CHTR2BMEN1KMT2APTGER1
SCHEMBL4775290 0.83 CA1 (0.52) HTR2CHTR2BMEN1KMT2ACYP2C9
SCHEMBL3917350 0.81 POLB (0.48) MEN1KMT2AMAPTL3MBTL1MRGPRX4
SCHEMBL527716 0.80 L3MBTL1 (0.53) MAPTL3MBTL1
SCHEMBL31728458 0.80 L3MBTL1 (0.53) MAPTL3MBTL1
SCHEMBL18923990 0.80 L3MBTL1 (0.53) MAPTL3MBTL1
SCHEMBL527717 0.80 L3MBTL1 (0.53) MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2768805-A1 (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS Oryzon Genomics, S.A. (ES) 2014-08-27 EP disclosed
WO-2013057320-A1 (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS ORYZON GENOMICS, S.A. (ES) 2013-04-25 WO disclosed